Management Team

David Bell is the Chief Corporate Development and Legal Officer at Grifols, where he leads Corporate Affairs, Data Protection, Special Projects and Compliance. Since joining Grifols in 2003 as General Counsel, Mr. Bell has been a member of the Executive Committee and the company’s Management Boards.

From 2016 to 2020, he served as Chief Innovation Officer, and in 2021, he was appointed Chief Corporate Development and Legal Officer, focusing on strategic partnerships and business expansion. Prior to his tenure at Grifols, Mr. Bell was Vice President and General Counsel, Corporate Secretary, at Alpha Therapeutic Corporation, and a partner at Knapp, Petersen & Clarke.

Mr. Bell earned his law degree from Southwestern University and holds a Bachelor of Science in Psychobiology from the University of California, Irvine. He also completed the Program of Instruction for Lawyers at Harvard Law School. For over a decade, he has served on the Global Board of Directors of the Plasma Protein Therapeutics Association (PPTA), acting as its Chairman from 2016 to 2019.